Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About Threshold Pharmaceuticals, Inc. (THLD)

Page 1 of 2

Is Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from industry insiders. They fail miserably sometimes, but historically their consensus stock picks outperformed the market after adjusting for known risk factors.

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) shareholders have witnessed an increase in support from the world’s most elite money managers lately. THLD was in 13 hedge funds’ portfolios at the end of the third quarter of 2015. There were 9 hedge funds in our database with THLD holdings at the end of the previous quarter. At the end of this article we will also compare THLD to other stocks, including Meta Financial Group Inc. (NASDAQ:CASH), Asanko Gold Inc (NYSEMKT:AKG), and Sodastream International Ltd (NASDAQ:SODA) to get a better sense of its popularity.

Follow Threshold Pharmaceuticals Inc (NASDAQ:THLD)
Trade (NASDAQ:THLD) Now!

According to most traders, hedge funds are seen as underperforming, old financial vehicles of years past. While there are more than 8000 funds with their doors open at the moment, We choose to focus on the bigwigs of this group, approximately 700 funds. These investment experts manage bulk of the smart money’s total asset base, and by tailing their best investments, Insider Monkey has formulated several investment strategies that have historically defeated Mr. Market. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points a year for a decade in their back tests.

Now, we’re going to view the key action surrounding Threshold Pharmaceuticals, Inc. (NASDAQ:THLD).

Hedge fund activity in Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

Heading into Q4, a total of 13 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 44% from one quarter earlier. With hedgies’ capital changing hands, there exists a few key hedge fund managers who were upping their stakes substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Julian Baker and Felix Baker’s Baker Bros. Advisors has the most valuable position in Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), worth close to $11.9 million, corresponding to 0.1% of its total 13F portfolio. The second largest stake is held by Millennium Management, led by Israel Englander, holding an $6.3 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Some other hedge funds and institutional investors with similar optimism comprise Phill Gross and Robert Atchinson’s Adage Capital Management, Jim Simons’ Renaissance Technologies and D. E. Shaw’s D E Shaw.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!